MedTrace Logo

Studies on Tumors of the Thyroid

NCT00001160 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2026-05-12

No results posted yet for this study

Summary

Participants in this study will be patients diagnosed with or suspected to have a thyroid nodule or thyroid cancer.

The main purpose of this study is to further understand the methods for the diagnosis and treatment of thyroid nodules and thyroid cancer. Many of the test performed are in the context of standard medical care that is offered to all patients with thyroid nodules or thyroid cancer. Other tests are performed for research purposes. In addition, blood and tissue samples will be taken for research and genetic studies.

Conditions

  • Hurthle Cell Thyroid Cancer
  • Tall Cell Variant Thyroid Cancer
  • Follicular Thyroid Cancer
  • Thyroid Cancer
  • Papillary Thyroid Cancer

Interventions

DRUG

68-Gallium Dotatate

For evaluation risk/benefit evaluation

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    lead NIH

Principal Investigators

  • Joanna Klubo-Gwiezdzinska, M.D. · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Eligibility

Min Age
6 Months
Max Age
98 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1977-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00001160 on ClinicalTrials.gov